Trial
NCT07087938
Cannabichromene Safety in Rheumatoid Arthritis
Phase ISUSPENDEDOPERATIONALConfidence: HIGH
Sponsor
Crystal Lederhos Smith
Collaborators
—
Condition
Arthritis, Rheumatoid
Intervention
Cannabichromene
Why stopped
This study was put on clinical hold with the FDA prior to beginning enrollment due to insufficient preclinical evidence.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-07-28